Business, Investing, and Partnering

Business, Investing, and Partnering will bring together multiple stakeholders from across precision medicine including investors, pharma partners, regulators, government, and start-up companies to discuss the opportunities and challenges presented by the current market. It will focus on Venture capital investment, Pharma partnering & licensing of novel technologies and drugs, Commercialization strategies, Market access, Regulation and reimbursement, How to manage multiple stakeholders: payers, patients, regulators, government, etc.